These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7441511

  • 1. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
    Hoffmann IS, Naylor RJ, Cubeddu LX.
    J Pharmacol Exp Ther; 1980 Nov; 215(2):486-93. PubMed ID: 7441511
    [Abstract] [Full Text] [Related]

  • 2. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP, Markstein R.
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [Abstract] [Full Text] [Related]

  • 3. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 4. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L, Crooks PA, Sonsalla PK, Dwoskin LP.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [Abstract] [Full Text] [Related]

  • 5. Effect of non-catecholic 2-aminotetralin derivatives on dopamine metabolism in the rat striatum.
    Feenstra MG, Rollema H, Dijkstra D, Grol CJ, Horn AS, Westerink BH.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):213-9. PubMed ID: 7432553
    [Abstract] [Full Text] [Related]

  • 6. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
    Dwoskin LP, Teng L, Buxton ST, Crooks PA.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
    [Abstract] [Full Text] [Related]

  • 7. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC.
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting properties.
    Hazelhoff B, De Vries JB, Dijkstra D, Mulder TB, Horn AS.
    Eur J Pharmacol; 1985 Feb 26; 109(2):229-40. PubMed ID: 3922776
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fluoro-gold and pentamidine inhibit the in vitro and in vivo release of dopamine in the striatum of rat.
    Bowyer JF, Gough B, Broening HW, Newport GD, Schmued L.
    J Pharmacol Exp Ther; 1993 Aug 26; 266(2):1066-74. PubMed ID: 8355181
    [Abstract] [Full Text] [Related]

  • 14. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C, Weiss M, Rostain JC.
    Brain Res; 2007 Oct 24; 1176():37-44. PubMed ID: 17900538
    [Abstract] [Full Text] [Related]

  • 15. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
    Niedzwiecki DM, Mailman RB, Cubeddu LX.
    J Pharmacol Exp Ther; 1984 Mar 24; 228(3):636-9. PubMed ID: 6707914
    [Abstract] [Full Text] [Related]

  • 16. Frequency-dependent release of acetylcholine and dopamine from rabbit striatum: its modulation by dopaminergic receptors.
    Cubeddu LX, Hoffmann IS.
    J Neurochem; 1983 Jul 24; 41(1):94-101. PubMed ID: 6864232
    [Abstract] [Full Text] [Related]

  • 17. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP, Markstein R.
    Mol Pharmacol; 1982 Sep 24; 22(2):281-9. PubMed ID: 7144729
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
    Sacaan AI, Dunlop JL, Lloyd GK.
    J Pharmacol Exp Ther; 1995 Jul 24; 274(1):224-30. PubMed ID: 7542334
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
    Gobert A, Lejeune F, Rivet JM, Audinot V, Newman-Tancredi A, Millan MJ.
    J Pharmacol Exp Ther; 1995 Jun 24; 273(3):1032-46. PubMed ID: 7791073
    [Abstract] [Full Text] [Related]

  • 20. Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: effects of age and sex.
    Glatt SJ, Trksak GH, Cohen OS, Simeone BP, Jackson D.
    Synapse; 2004 Aug 24; 53(2):74-89. PubMed ID: 15170820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.